Doxorubicin inhibits muscle inflammation after eccentric exercise

BACKGROUND: Doxorubicin, a widely used anti‐tumour drug, is known to cause muscle loss in cancer patients. METHODS: Following an acute dose of doxorubicin injection (2.5 mg/kg per body weight), we examined macrophage distribution in rat soleus muscle challenged by eccentric exercise (downhill runnin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cachexia Sarcopenia Muscle
Autors principals: Huang, Sheng‐Chih, Wu, Jin‐Fu, Saovieng, Suchada, Chien, Wei‐Horng, Hsu, Ming‐Fen, Li, Xiao‐Fei, Lee, Shin‐Da, Huang, Chih‐Yang, Kuo, Chia‐Hua
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5377412/
https://ncbi.nlm.nih.gov/pubmed/27897404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12148
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars